Plitidepsin (Aplidin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Plitidepsin (Aplidin), covering 2020-12-02 to 2020-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and Lenalidomide [Phase 2]